# US 2026/0097041 A1 · Fluoro beta-carboline compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0097041 A1
- Document ID: US20260097041A1
- Status: Published application
- Kind: A1
- Application number: 19/202,018
- Filed: 2025-05-08
- Published: 2026-04-09
- Earliest claimed: 2018-08-14
- Assignees: Ossifi Therapeutics LLC
- Applicants: Ossifi Therapeutics LLC
- Inventors: Debra ELLIES; F. Scott KIMBALL; Robert N. YOUNG
- Web page: https://patentgrep.com/patent/US20260097041A1

## CPC

- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 31/444: containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A61K 31/496: Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A61K 31/5386: spiro-condensed or forming part of bridged ring systems
- A61K 31/55: having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61K 39/3955: {against proteinaceous materials, e.g. enzymes, hormones, lymphokines}
- A61P 19/10: for osteoporosis
- C07D 471/04: Ortho-condensed systems
- C07D 491/048: the oxygen-containing ring being five-membered
- C07D 498/08: Bridged systems
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes, bone loss, and cancer, using a compound of Formula I.

## Claims

### Claim at position 1

1-52. (canceled)

### Claim 53

A medical device comprising a structural support, wherein an implantable portion of the structural support is adapted to be permanently implanted within a subject, wherein the implantable portion is attached to a bone, the structural support bearing at least a partial external coating comprising a compound and/or the structural support comprising a compound within the support,
wherein the compound is selected from the group consisting of:
or a pharmaceutically acceptable salt, hydrate or prodrug thereof.

### Claim 54

(canceled)

### Claim 55 (depends on 53)

The device of claim 53, wherein the structural support bears at least a partial external coating that comprises the compound.

### Claim 56 (depends on 53)

The device of claim 53, wherein the compound is within the support.

### Claim 57 (depends on 53)

The device of claim 53, wherein the structural support comprises at least a partial external coating comprising the compound and also comprises the compound within the support.

### Claim 58 (depends on 53)

The device of claim 53, wherein the device is an orthopedic or periodontal medical device.

### Claim 59 (depends on 53)

The device of claim 53, wherein the implantable portion is at least partially or totally covered or impregnated with the compound.

### Claim 60 (depends on 53)

The device of claim 53, wherein the external coating completely coats the implantable portion of the structural support.

### Claim 61 (depends on 53)

The device of claim 53, wherein the structural support is a titanium cage, pin, rod, screw, an orthopedic implant, or a periodontal implant.

### Claim 62 (depends on 53)

The device of claim 53, wherein the structural support comprises a material selected from metal, polymer, ceramic, and combinations thereof.

### Claim 63 (depends on 53)

The device of claim 53, wherein the metal comprises stainless steel, cobalt, chromium, titanium, or tantalum.

### Claim 64 (depends on 62)

The device of claim 62, wherein the metal is chromium, titanium alloy, or trabecular metal.

### Claim 65 (depends on 62)

The device of claim 62, wherein the ceramic is aluminum oxide, calcium phosphates, hydroxyapatite, zirconium oxide, or silicon oxide.

### Claim 66 (depends on 53)

The device of claim 53, wherein the structural support is a scaffold or a matrix comprising a synthetic material, a biologic material, or a combination thereof.

### Claim 67 (depends on 53)

The device of claim 53, wherein the structural support is a scaffold or a matrix comprising a naturally occurring polymer, a synthetic biodegradable polymer, a synthetic nonbiodegradable polymer, a bioceramic, a bioactive glass, or combinations thereof.

### Claim 68 (depends on 67)

The device of claim 67 wherein the natural occurring polymer is protein, polysaccharide or polynucleotide.

### Claim 69 (depends on 68)

The device of claim 68, wherein the protein is selected from the group consisting of silk, collagen, gelatin, fibrinogen, elastin, keratin, actin, and myosin, and the polysaccharide is selected from the group consisting of cellulose, amylose, dextran, chitin, chitosan, and glycosaminoglycans.

### Claim 70 (depends on 67)

The device of claim 67, wherein the synthetic polymer is selected from the group consisting of PLA, PGA, PLLA, PLGA, PCL, PLDLA, PDS, PGCL, PEA, PCA, PDLLA, PEU, and PBT.

### Claim 71 (depends on 53)

The medical device of claim 53, wherein the structural support is a scaffold or a matrix comprising CP ceramics.

### Claim 72 (depends on 53)

The medical device of claim 53, wherein the structural support comprises an osteoconductive matrix.

### Claim 73 (depends on 72)

The medical device of claim 72, wherein the matrix comprises particles of porous materials.
